(Q34341910)

1 August 2017

1 reference

title

Menopause, hormone replacement therapy and cancer (English)

1 reference

Hormone Replacement Therapy

1 August 2017

1 reference

1

1 reference

1 August 2017

2

Brinton LA

1 reference

1 August 2017

McTiernan A

3

1 reference

1 August 2017

1 August 2001

1 reference

1 August 2017

1 reference

1 August 2017

39

1 reference

1 August 2017

97-115

1 reference

1 August 2017

2

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

1 August 2017

1 reference

7 January 2021

Reproductive surgery, menopause and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

The menopause and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Menstrual factors and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Risk of breast cancer in relation to reproductive factors in Denmark

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Risk factors for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Problems involved in including women with simple hysterectomy in epidemiologic studies measuring the effects of hormone replacement therapy on breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Age at menopause and breast cancer: estimation of floating absolute risks

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

The epidemiology of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

The epidemiology of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Postmenopausal hormone-replacement therapy--time for a reappraisal?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Sex hormones and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Colorectal cancer and hormone replacement therapy: an unexpected finding

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Postmenopausal hormone therapy and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

The adverse effects of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormone replacement and breast cancer. A remaining controversy?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Estrogen replacement therapy and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Exogenous progestins and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

The risk of breast cancer after estrogen and estrogen-progestin replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Long-term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Postmenopausal estrogens--opposed, unopposed, or none of the above

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

The cancer question: an overview of recent epidemiologic and retrospective data

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormone replacement treatment and breast cancer risk: a cooperative Italian study.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Benefits and risks of estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Mammographic features and breast cancer risk: effects with time, age, and menopause status.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Decreased mortality in users of estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Estrogen Replacement Therapy and Breast Cancer Survival in a Large Screening Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Elements of informed consent for hormone replacement therapy in patients with diagnosed breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormone replacement therapy and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Association of Exogenous Estrogen and Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

The influence of exogenous estrogen use on survival after diagnosis of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Endometrial cancer risk after discontinuing use of unopposed conjugated estrogens (California, United States).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Oestrogens and obesity as risk factors for endometrial cancer in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

The antiestrogenic effect of cigarette smoking in women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Oestrogen replacement treatment and the risk of endometrial cancer: an assessment of the role of covariates

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Exposure to phenoxy herbicides and the risk of spontaneous abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Population attributable risk for endometrial cancer in northern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Estrogen-progestin replacement therapy and endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormone replacement therapy and endometrial cancer: are current regimens safe?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Cancer mortality in Europe: effects of age, cohort of birth and period of death.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Cause-specific mortality in women receiving hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Estrogen replacement therapy and fatal ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Noncontraceptive estrogen use and epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Risk factors for ovarian cancer: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

The epidemiology of ovarian cancer in Greece: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Estrogen replacement therapy and ovarian cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

An epidemiologic study of epithelial carcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Risk factors for epithelial ovarian cancer in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormone replacement therapy and risk of epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Postmenopausal hormone use and risk of large-bowel cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Postmenopausal hormone use and risk for colorectal cancer and adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Postmenopausal estrogen and prevention bias

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Reproductive factors and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

The influence of reproductive and hormonal factors on the risk of colon and rectal cancer in women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Risk of cancer in women receiving hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Re: Endocrine factors and adenocarcinoma of the lung in women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Female hormone utilisation and risk of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Nonviral Risk Factors for Hepatocellular Carcinoma in a Low-Risk Population, the Non-Asians of Los Angeles County, California

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Case-control study of oestrogen replacement therapy and risk of cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Phytoestrogens: the "natural" selective estrogen receptor modulators?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormone replacement therapy and endometrial cancer in Ontario, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

A prospective study of menopausal hormones and risk of colorectal cancer (United States)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Estrogen replacement therapy and colorectal cancer risk in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

The influence of parity and exogenous female hormones on the risk of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Reproductive factors and colon cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Reproductive factors, exogenous female hormones, and colorectal cancer by subsite

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2801%2900213-4

7 January 2021

10.1016/S0378-5122(01)00213-4

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11514109